Healthcare provider profile · identity verified

James W Pickens, MD

Family Practice · WAXAHACHIE, TX · NPI 1982610408

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	361	106
Atorvastatin Calcium	Atorvastatin Calcium	275	82
Metformin Hcl	Metformin Hcl	248	64
Levothyroxine Sodium	Levothyroxine Sodium	244	68
Lisinopril	Lisinopril	230	66
Pantoprazole Sodium	Pantoprazole Sodium	216	49
Losartan Potassium	Losartan Potassium	195	53
Gabapentin	Gabapentin	193	48
Alprazolam	Alprazolam	191	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	184	24
Tamsulosin Hcl	Tamsulosin Hcl	150	41
Metoprolol Succinate	Metoprolol Succinate	145	42
Rosuvastatin Calcium	Rosuvastatin Calcium	140	40
Albuterol Sulfate Hfa	Albuterol Sulfate	127	40
Trazodone Hcl	Trazodone Hcl	127	30
Carvedilol	Carvedilol	123	37
Furosemide	Furosemide	123	40
Meloxicam	Meloxicam	116	29
Pravastatin Sodium	Pravastatin Sodium	112	30
Escitalopram Oxalate	Escitalopram Oxalate	109	24
Cefdinir	Cefdinir	105	85
Omeprazole	Omeprazole	104	33
Tramadol Hcl	Tramadol Hcl	103	26
Eliquis	Apixaban	101	23
Ozempic	Semaglutide	98	14
Hydrochlorothiazide	Hydrochlorothiazide	95	29
Zolpidem Tartrate	Zolpidem Tartrate	94	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	16
Metoprolol Tartrate	Metoprolol Tartrate	82	21
Fluticasone Propionate	Fluticasone Propionate	71	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	19
Montelukast Sodium	Montelukast Sodium	70	19
Glimepiride	Glimepiride	65	13
Duloxetine Hcl	Duloxetine Hcl	64	16
Potassium Chloride	Potassium Chloride	63	16
Hydralazine Hcl	Hydralazine Hcl	55	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	14
Glipizide	Glipizide	46	13
Temazepam	Temazepam	45	suppressed
Allopurinol	Allopurinol	44	13
Azithromycin	Azithromycin	44	35
Simvastatin	Simvastatin	44	12
Quetiapine Fumarate	Quetiapine Fumarate	43	13
Pioglitazone Hcl	Pioglitazone Hcl	41	12
Clopidogrel	Clopidogrel Bisulfate	40	16
Spironolactone	Spironolactone	40	suppressed
Finasteride	Finasteride	39	suppressed
Pregabalin	Pregabalin	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Lovastatin	Lovastatin	36	suppressed
Methylprednisolone	Methylprednisolone	36	29
Diazepam	Diazepam	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	29
Acetaminophen-Codeine	Acetaminophen With Codeine	34	11
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Nifedipine Er	Nifedipine	29	11
Famotidine	Famotidine	28	suppressed
Prednisone	Prednisone	28	17
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Ramipril	Ramipril	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Methocarbamol	Methocarbamol	24	17
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Nabumetone	Nabumetone	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Torsemide	Torsemide	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	14
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Cephalexin	Cephalexin	17	12
Meclizine Hcl	Meclizine Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Xarelto	Rivaroxaban	15	suppressed
Jardiance	Empagliflozin	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Mupirocin	Mupirocin	12	11
Altace	Ramipril	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Penicillin V Potassium	Penicillin V Potassium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error